Vasoactive intestinal polypeptide concentrations in heart atria of hypothyroid rats
Status PubMed-not-MEDLINE Language English Country Canada Media print
Document type Journal Article
PubMed
20428449
PubMed Central
PMC2858988
Knihovny.cz E-resources
- Keywords
- Atria, Development, Hypothyroidism, Rat, Vasoactive intestinal polypeptide,
- Publication type
- Journal Article MeSH
OBJECTIVES: To determine putative effects of various protocols of propylthiouracil (PTU)-induced hypothyroidism on vasoactive intestinal polypeptide-like immunoreactivity (VIP-LI) levels in the atria of developing and adult female rats. ANIMALS AND METHODS: Perinatal hypothyroidism was induced by treating pregnant rats with 0.05% PTU in drinking water from late gestation till the age of 60 days (P-PTU). Adult rats were given PTU for 10, 30 or 70 days (PTU-10, PTU-30 and PTU-70, respectively). Corresponding age-matched controls were left intact (P-Cont, Cont-10, Cont-30 and Cont-70, respectively). Resting heart rate, serum total thyroxine concentration, body weight and atrial weight were determined in all animals. VIP-LI levels in tissue extracts were measured by radioimmunoassay. RESULTS: The values of heart rate, serum total thyroxine, body weight and atrial weight showed that 10-day treatment did not suppress thyroid gland function completely. However, the remaining experimental protocols were sufficient to reach stable hypothyroid conditions. Thyroid hormone deficiency led to a significant increase in VIP-LI levels in both atria of PTU-30 and PTU-70 rats (P<0.01 versus corresponding controls). Interestingly, in P-PTU atria, VIP-LI reached significantly higher values than in rats treated with PTU for the same time during adulthood (PTU-70). CONCLUSIONS: These results provide new evidence that hypothyroidism interferes with VIP-ergic innervation in rat heart atria. The impact of thyroid hormone deficiency on VIP-LI levels differed in P-PTU and PTU-70 rats suggesting that thyroid hormone may play an important part in the development of VIP-ergic innervation in rat heart atria.
See more in PubMed
Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation. 1993;87:1435–41. PubMed
Inukai T, Kobayashi I, Kobayashi T, et al. Parasympathetic nervous system activity in hypothyroidism determined by R-R interval variations on electrocardiogram. J Intern Med. 1990;228:431–4. PubMed
Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI, Schwaiger M. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab. 2000;85:1822–7. PubMed
Biondi B, Fazio S, Palmieri EA, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1999;84:2064–7. PubMed
Zwaveling J, Batink HD, de Jong J, Winkler Prins EA, Pfaffendorf M, van Zwieten PA. Thyroid hormone modulates inotropic responses, α-adrenoceptor density and catecholamine concentrations in the rat heart. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:755–64. PubMed
Gross G, Lues I. Thyroid-dependent alterations of myocardial adrenoceptors and adrenoceptor-mediated responses in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1985;329:427–39. PubMed
Swann AC. Thyroid hormone and norepinephrine: effects on alpha-2, beta and reuptake sites in cerebral cortex and heart. J Neural Transm. 1988;71:195–205. PubMed
Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on α- and β-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev. 1983;4:378–88. PubMed
Limas C, Limas CJ. Influence of thyroid status on intracellular distribution of cardiac adrenoceptors. Circ Res. 1987;61:824–8. PubMed
Robberecht P, Waelbroeck M, Claeys M, Huu AN, Chatelain P, Christophe J. Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy. Mol Pharmacol. 1982;21:589–93. PubMed
Sharma VK, Banerjee SP. Muscarinic cholinergic receptors in rat heart. Effects of thyroidectomy. J Biol Chem. 1977;252:7444–6. PubMed
Weihe E, Reinecke M, Forssmann WG. Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nerves. Cell Tissue Res. 1984;236:527–40. PubMed
Slavíková J. Distribution of peptide-containing neurons in the developing rat right atrium, studied using immunofluorescence and confocal laser scanning. Neurochem Res. 1997;22:1013–21. PubMed
Kalfin R, Maulik N, Engelman RM, et al. Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J Pharmacol Exp Ther. 1994;268:952–8. PubMed
Shvilkin A, Danilo P, Jr, Chevalier P, Chang F, Cohen IS, Rosen MR. Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart. Cardiovasc Res. 1994;28:1769–73. PubMed
Anderson FL, Kralios AC, Hershberger R, Bristow MR. Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. J Cardiovasc Pharmacol. 1988;12:365–71. PubMed
Kuncová J, Slavíková J. Vasoactive intestinal polypeptide in rat heart atria: the effect of hyperthyroidism. Physiol Res. 2000;49:427–34. PubMed
Thompson EB, Lum L. A time-course study of hypothyroidism-induced hypotension: its relation to hypothermia. Arch Int Pharmacodyn Ther. 1986;283:141–52. PubMed
Leret ML, Fraile A. Influence of thyroidectomy on brain catecholamines during the postnatal period. Comp Biochem Physiol. 1986;83C:117–21. PubMed
Tsuchiya T, Suzuki Y, Suzuki H, Ohtake R, Shimoda SI. Changes in adrenal neuropeptides content [peptide 7B2, neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP)] induced by pharmacological and hormonal manipulations. J Endocrinol Invest. 1990;13:381–9. PubMed
Lam KS. Vasoactive intestinal peptide in the hypothalamus and pituitary. Neuroendocrinology. 1991;53(Suppl 1):45–51. PubMed
Toni R, Kakucska I, Mosca S, Marrama P, Lechan RM. Hypothyroidism increases vasoactive intestinal polypeptide (VIP) immunoreactivity and gene expression in the rat hypothalamic paraventricular nucleus. Endocrinology. 1992;131:976–8. PubMed
Buhl T, Georg B, Nilsson C, Mikkelsen JD, Wulff BS, Fahrenkrug J. Effect of thyroid hormones on vasoactive intestinal polypeptide gene expression in the rat cerebral cortex and anterior pituitary. Regul Pept. 1995;55:237–51. PubMed
Slotkin TA, Slepetis RJ. Obligatory role of thyroid hormones in development of peripheral sympathetic and central nervous system catecholaminergic neurons: effects of propylthiouracil-induced hypothyroidism on transmitter levels, turnover and release. J Pharmacol Exp Ther. 1984;230:53–61. PubMed
Ip NY, Baldwin C, Zigmond RE. Regulation of the concentration of adenosine 3′, 5′-cyclic monophosphate and the activity of tyrosine hydroxylase in the rat superior cervical ganglion by three neuropeptides of the secretin family. J Neurosci. 1985;5:1947–54. PubMed PMC
Klimaschewski L, Unsicker K, Heym C. Vasoactive intestinal peptide but not galanin promotes survival of neonatal rat sympathetic neurons and neurite outgrowth of PC12 cells. Neurosci Lett. 1995;195:133–6. PubMed
Kuncová J, Slavíková J.Vasoactive intestinal peptide in heart atria of hypothyroid and hyperthyroid rats Physiol Res 199948S89(Abst)